Tapewire

NYSE · USD

AX

Axos Financial, Inc.

Export transactions ↓
Tapewire entity
3860
SEC CIK
0001299709
Parsed reports
756

Last 12 months

Inside the activity.

0 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202600
Feb 202607
Mar 202600
Apr 202600
May 202602
Jun 202601
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 08, 2016 Filed Sep 12, 2016 23:19 UTC GrantRestricted Stock Units · Derivative 8,000 $0.00 $0.00
Disclosure

SEC source: 0001299709-16-000293 · edgardoc.xml · derivative · entry 1

Burke John Gary · CIK 0001345768 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,002

Underlying: Common Stock · 8,000 shares

Expires not disclosed

F1 · security: Grant to the reporting person on September 8, 2016 of restricted stock units (RSUs) under the BofI Holding, Inc. 2014 Stock Incentive Plan in connection with the reporting person's service as a member of the Board of Directors.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of BofI Holding, Inc. Common Stock. The RSUs are accompanied by dividend equivalent rights.

F3 · derivative.exercise_date: The RSUs vest over three years, one third on August 24 of each of the three years following the date of grant.

F3 · derivative.expiration_date: The RSUs vest over three years, one third on August 24 of each of the three years following the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.